Although LIN28B has predominantly been reported to have a pro-leukemic role in AML (Zhou et al., 2017), one study on a murine KMT2A::MLLT3 AML model suggests that LIN28B abrogates perinatal leukemia development (Eldeeb et al., 2023). Here, LIN28B is linked to leukemia.